| Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation JM Unger, R Vaidya, DL Hershman, LM Minasian, ME Fleury JNCI: Journal of the National Cancer Institute 111 (3), 245-255, 2019 | 494 | 2019 |
| “When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials JM Unger, DL Hershman, C Till, LM Minasian, RU Osarogiagbon, ... JNCI: Journal of the National Cancer Institute 113 (3), 244-257, 2021 | 219 | 2021 |
| Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials JM Unger, R Vaidya, KS Albain, M LeBlanc, LM Minasian, CC Gotay, ... Journal of Clinical Oncology 40 (13), 1474-1486, 2022 | 201 | 2022 |
| Association of patient comorbid conditions with cancer clinical trial participation JM Unger, DL Hershman, ME Fleury, R Vaidya JAMA oncology 5 (3), 326-333, 2019 | 148 | 2019 |
| Sex, racial, and ethnic representation in COVID-19 clinical trials: a systematic review and meta-analysis H Xiao, R Vaidya, F Liu, X Chang, X Xia, JM Unger JAMA internal medicine 183 (1), 50-60, 2023 | 49 | 2023 |
| Association of patient demographic characteristics and insurance status with survival in cancer randomized clinical trials with positive findings JM Unger, CD Blanke, M LeBlanc, WE Barlow, R Vaidya, SD Ramsey, ... JAMA Network Open 3 (4), e203842-e203842, 2020 | 44 | 2020 |
| Association of National Cancer Institute–sponsored clinical trial network group studies with guideline care and new drug indications JM Unger, VT Nghiem, DL Hershman, R Vaidya, M LeBlanc, CD Blanke JAMA Network Open 2 (9), e1910593-e1910593, 2019 | 29 | 2019 |
| Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials JM Unger, R Vaidya, JL Gore Urologic Oncology: Seminars and Original Investigations 37 (5), 324-330, 2019 | 16 | 2019 |
| Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials. JM Unger, R Vaidya, KS Albain, ML LeBlanc, LM Minasian, C Gotay, ... Journal of Clinical Oncology 37 (15_suppl), 11588-11588, 2019 | 10 | 2019 |
| Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies JM Unger, M LeBlanc, S George, N Wolmark, WJ Curran Jr, PJ O'Dwyer, ... Journal of Clinical Oncology 41 (11), 2020-2028, 2023 | 9 | 2023 |
| Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials DL Hershman, C Till, JD Wright, M Accordino, R Vaidya, WE Barlow, ... Breast cancer research and treatment 181, 455-463, 2020 | 9 | 2020 |
| Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics A Bell-Brown, K Watabayashi, D Delaney, RC Carlos, SL Langer, ... JNCI Cancer Spectrum 7 (5), pkad055, 2023 | 8 | 2023 |
| Medicaid expansion of the Patient Protection and Affordable Care Act and participation of patients with Medicaid in cancer clinical trials JM Unger, H Xiao, R Vaidya, M LeBlanc, DL Hershman JAMA oncology 9 (10), 1371-1379, 2023 | 7 | 2023 |
| Trends in obesity prevalence among patients enrolled in Clinical Trials for obesity-related cancers, 1986 to 2016 R Vaidya, C Till, H Greenlee, DL Hershman, JM Unger JAMA Network Open 5 (10), e2234445-e2234445, 2022 | 7 | 2022 |
| Economic Evaluations in National Cancer Institute–Sponsored Network Cancer Clinical Trials VT Nghiem, R Vaidya, GH Lyman, DL Hershman, SD Ramsey, JM Unger Value in Health 23 (12), 1653-1661, 2020 | 5 | 2020 |
| The Medicaid expansion of the Affordable Care Act and participation of patients with Medicaid in cancer clinical trials. JM Unger, H Xiao, R Vaidya, DL Hershman Journal of Clinical Oncology 40 (16_suppl), 6505-6505, 2022 | 4 | 2022 |
| Patterns of scientific and clinical impact in cancer randomized clinical trials VT Nghiem, R Vaidya, JM Unger JAMA Network Open 5 (6), e2219657-e2219657, 2022 | 4 | 2022 |
| Patient enrollment to industry-sponsored versus federally-sponsored cancer clinical trials JM Unger, H Xiao, R Vaidya, M LeBlanc Journal of Clinical Oncology 42 (33), 3917-3925, 2024 | 3 | 2024 |
| Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022 H Xiao, R Vaidya, DL Hershman, JM Unger Journal of Clinical Oncology, JCO. 23.01777, 2024 | 3 | 2024 |
| Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials. DL Hershman, C Till, JD Wright, MK Accordino, R Vaidya, WE Barlow, ... Journal of Clinical Oncology 37 (15_suppl), 11508-11508, 2019 | 3 | 2019 |
